DFO
BMRN icon

Duquesne Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History

Duquesne Family Office’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-192,700
Closed -$16.9M – 64
2020
Q4 		$16.9M Hold
192,700
– – 0.46% 40
2020
Q3 		$14.7M Hold
192,700
– – 0.43% 41
2020
Q2 		$23.8M Buy
+192,700
New +$23.8M 0.73% 33